195 related articles for article (PubMed ID: 10747889)
1. Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation.
Argiriadi MA; Morisseau C; Goodrow MH; Dowdy DL; Hammock BD; Christianson DW
J Biol Chem; 2000 May; 275(20):15265-70. PubMed ID: 10747889
[TBL] [Abstract][Full Text] [Related]
2. The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor.
Biswal BK; Morisseau C; Garen G; Cherney MM; Garen C; Niu C; Hammock BD; James MN
J Mol Biol; 2008 Sep; 381(4):897-912. PubMed ID: 18585390
[TBL] [Abstract][Full Text] [Related]
3. Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis.
Gomez GA; Morisseau C; Hammock BD; Christianson DW
Biochemistry; 2004 Apr; 43(16):4716-23. PubMed ID: 15096040
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
[TBL] [Abstract][Full Text] [Related]
5. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
Chen H; Zhang Y; Ye C; Feng TT; Han JG
J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase.
Yamada T; Morisseau C; Maxwell JE; Argiriadi MA; Christianson DW; Hammock BD
J Biol Chem; 2000 Jul; 275(30):23082-8. PubMed ID: 10806198
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine residues serve as proton donor in the catalytic mechanism of epoxide hydrolase from Agrobacterium radiobacter.
Rink R; Kingma J; Lutje Spelberg JH; Janssen DB
Biochemistry; 2000 May; 39(18):5600-13. PubMed ID: 10820034
[TBL] [Abstract][Full Text] [Related]
8. Implications for an ionized alkyl-enzyme intermediate during StEH1-catalyzed trans-stilbene oxide hydrolysis.
Elfström LT; Widersten M
Biochemistry; 2006 Jan; 45(1):205-12. PubMed ID: 16388596
[TBL] [Abstract][Full Text] [Related]
9. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
[TBL] [Abstract][Full Text] [Related]
10. Epoxide hydrolase-catalyzed enantioselective conversion of trans-stilbene oxide: Insights into the reaction mechanism from steady-state and pre-steady-state enzyme kinetics.
Archelas A; Zhao W; Faure B; Iacazio G; Kotik M
Arch Biochem Biophys; 2016 Feb; 591():66-75. PubMed ID: 26714303
[TBL] [Abstract][Full Text] [Related]
11. 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues.
Nakagawa Y; Wheelock CE; Morisseau C; Goodrow MH; Hammock BG; Hammock BD
Bioorg Med Chem; 2000 Nov; 8(11):2663-73. PubMed ID: 11092551
[TBL] [Abstract][Full Text] [Related]
12. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids.
Gomez GA; Morisseau C; Hammock BD; Christianson DW
Protein Sci; 2006 Jan; 15(1):58-64. PubMed ID: 16322563
[TBL] [Abstract][Full Text] [Related]
13. A theoretical examination of the acid-catalyzed and noncatalyzed ring-opening reaction of an oxirane by nucleophilic addition of acetate. Implications to epoxide hydrolases.
Lau EY; Newby ZE; Bruice TC
J Am Chem Soc; 2001 Apr; 123(14):3350-7. PubMed ID: 11457071
[TBL] [Abstract][Full Text] [Related]
14. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
Anandan SK; Gless RD
Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
[TBL] [Abstract][Full Text] [Related]
15. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.
Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K
Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361
[TBL] [Abstract][Full Text] [Related]
16. Asp333, Asp495, and His523 form the catalytic triad of rat soluble epoxide hydrolase.
Arand M; Wagner H; Oesch F
J Biol Chem; 1996 Feb; 271(8):4223-9. PubMed ID: 8626766
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene A4 hydrolase: identification of a common carboxylate recognition site for the epoxide hydrolase and aminopeptidase substrates.
Rudberg PC; Tholander F; Andberg M; Thunnissen MM; Haeggström JZ
J Biol Chem; 2004 Jun; 279(26):27376-82. PubMed ID: 15078870
[TBL] [Abstract][Full Text] [Related]
18. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
[TBL] [Abstract][Full Text] [Related]
19. Reaction mechanism of soluble epoxide hydrolase: insights from molecular dynamics simulations.
Schiøtt B; Bruice TC
J Am Chem Soc; 2002 Dec; 124(49):14558-70. PubMed ID: 12465965
[TBL] [Abstract][Full Text] [Related]
20. Homology modeling of a novel epoxide hydrolase (EH) from Aspergillus niger SQ-6: structure-activity relationship in expoxides inhibiting EH activity.
Luo Q; Yao Y; Han WW; Zhou YH; Li ZS
J Mol Model; 2009 Sep; 15(9):1125-32. PubMed ID: 19234727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
